Overview

A Multicenter, Randomized, Open, Parallel-designed Study to Evaluate the Efficacy and Safety of HRS-5635 Injection Alone or in Combination With Other Agents in Patients Treated for Chronic Hepatitis B

Status:
RECRUITING
Trial end date:
2027-01-19
Target enrollment:
Participant gender:
Summary
A multicenter, randomized, open, parallel-designed Phase II study to evaluate the efficacy and safety of HRS-5635 injection alone or in combination with other agents in patients treated for chronic hepatitis B.
Phase:
PHASE2
Details
Lead Sponsor:
Fujian Shengdi Pharmaceutical Co., Ltd.